Skip to main content
SpringerLink
Log in

Drug Abuse and Addiction in Elderly

  • Chapter
  • First Online:
Drug Abuse and Addiction in Medical Illness

Abstract

Misuse and abuse of legal and illegal drugs constitute a current and growing problem among older adults. This chapter reviews the prevalence, risks and protective factors, screening and diagnosis, and treatment of drug abuse in older adults. Despite a wealth of information on the epidemiology and treatment of alcohol abuse in older adults, few data are available on drug abuse in this population. Limited evidence suggests that although illegal drug use among older adults is relatively rare compared to younger adults and adolescents, there is a growing problem of prescription drug misuse and abuse, with nonmedical use of prescription drugs among all adults aged ≥50 years estimated to increase to 2.7 million by 2020. Factors associated with drug misuse and abuse in older adults include female sex, social isolation, history of a substance use or mental health disorder, and medical exposure to prescription drugs with abuse potential. The paucity of validated screening and assessment instruments impedes the identification and diagnoses of substance use disorders in the older population. Thus, special approaches may be necessary when treating substance use disorders in older adults with multiple comorbidities and/or functional impairment, with the least intensive approaches considered first. In conclusion, psychoactive medications with abuse potential are used by at least one in four older adults. The treatment of substance use disorders in older adults may involve family and caretakers, and should take into account the unique physical, emotional, and cognitive factors associated with aging. Further research should focus on epidemiologic, health services, and screening and treatment aspects of drug abuse in older adults.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Culberson J, Ziska M. Prescription drug misuse/abuse in the elderly. Geriatrics. 2008;63(9):22–31.

    PubMed  Google Scholar 

  2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: APA; 1994.

    Google Scholar 

  3. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997;157(14):1531–6.

    Article  PubMed  CAS  Google Scholar 

  4. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151(9):1825–32.

    Article  PubMed  CAS  Google Scholar 

  5. Briesacher B, Limcangco R, Simoni-Wastila L, Doshi J, Gurwitz J. Evaluation of nationally-mandated drug use reviews to improve patient safety in nursing homes: a natural experiment. J Am Geriatr Soc. 2005;53(6):991–8.

    Article  PubMed  Google Scholar 

  6. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal ­studies: development and validation. J Chronic Dis. 1987;40(5):373–83.

    Article  PubMed  CAS  Google Scholar 

  7. SAMHSA. Substance abuse among older adults. Rockville, MD: Substance Abuse and Mental Health Services Administration. Center for Substance Abuse Treatment; 1998. DHHS Publication Number SMA 98–3179.

    Google Scholar 

  8. Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. J Am Med Assoc. 2001;286(22):2823–9.

    Article  CAS  Google Scholar 

  9. Cowan C. Coverage, sample design, and weighting in three federal surveys. J Drug Issues. 2001;31:599–614.

    Google Scholar 

  10. Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. J Am Med Assoc. 2000;283(13):1710–4.

    Article  CAS  Google Scholar 

  11. Blow FC. Substance abuse among older adults treatment protocol (TIP). Rockville, MD: USDHSS/PHS/SAMHSA Center for Substance Abuse Treatment; 2001.

    Google Scholar 

  12. Menninger JA. Assessment and treatment of alcoholism and substance-related disorders in the elderly. Bull Menninger Clin. 2002;66(2):166–83.

    Article  PubMed  Google Scholar 

  13. Jinks MJ, Raschko RR. A profile of alcohol and prescription drug abuse in a high-risk community-based elderly population. DICP. 1990;24(10):971–5.

    PubMed  CAS  Google Scholar 

  14. Ray WA, Thapa PB, Shorr RI. Medications and the older driver. Clin Geriatr Med. 1993;9(2):413–38.

    PubMed  CAS  Google Scholar 

  15. Solomon K, Manapelli J, Ireland G, Mahon G. Alcoholism and prescription drug abuse in the elderly: St Louis grand rounds. J Am Geriatr Soc. 1993;41(1):57–69.

    PubMed  CAS  Google Scholar 

  16. Finlayson R. Misuse of prescription drugs. Int J Addict. 1995;301(13 and 14):1871–901.

    Google Scholar 

  17. Salzman C. Benzodiazepine dependence, toxicity, and abuse: a task force report of the American Psychiatric Association. Washington, DC: American Psychiatric Association; 1990.

    Google Scholar 

  18. Salzman C. Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse. J Psychiatr Res. 1993;27:97–110.

    Article  PubMed  Google Scholar 

  19. Salzman C. Issues and controversies regarding benzodiazepine use. Washington, DC: NIDA; 1993. NIDA Research Monograph Series no. 131; NIH Pub. No. 93–3507.

    Google Scholar 

  20. Fingeld-Connett DL. Treatment of substance misuse in older women: using a brief intervention model. J Gerontol Nursing. 2004;30(8):30–7.

    Google Scholar 

  21. Woods J, Winger G. Current benzodiazepine issues. Psychopharmacology. 1995;118(2):107–15.

    Article  PubMed  CAS  Google Scholar 

  22. Hanlon JT, Horner RD, Schmader KE, et al. Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther. 1998;64(6):684–92.

    Article  PubMed  CAS  Google Scholar 

  23. Sheahan SL, Coons SJ, Robbins CA, Martin SS, Hendricks J, Latimer M. Psychoactive medication, alcohol use, and falls among older adults. J Behav Med. 1995;18(2):127–40.

    Article  PubMed  CAS  Google Scholar 

  24. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I Psychotropic drugs. J Am Geriatr Soc. 1999;47(1):30–9.

    PubMed  CAS  Google Scholar 

  25. Fouts M, Rachow J. Choice of hypnotics in the elderly. P and T News. 1994;14(8):1–4.

    Google Scholar 

  26. Anthony J, Helzer J. Syndromes of drug abuse and dependence. In: Robins L, Regier D, editors. Psychiatric disorders in America: the epidemiologic catchment area study. New York: The Free Press; 1991. p. 116–54.

    Google Scholar 

  27. SAMHSA. The DASIS Report: Older Adults in Substance Abuse Treatment. The DASIS Report; 2005.

    Google Scholar 

  28. Prigerson HG, Desai RA, Rosenheck RA. Older adult patients with both psychiatric and substance abuse disorders: prevalence and health service use. Psychiatr Quart. 2001;72(1):1–18.

    Article  CAS  Google Scholar 

  29. Rosen D, Smith M, Reynolds C. The prevalence of mental and physical health disorders among older methadone patients. Am J Geriatr Psychiatr. 2008;16(6):488–97.

    Article  Google Scholar 

  30. Hser Y, Anglin D, Powers K. A 24-year follow-up of California narcotics addicts. Arch Gen Psychiatr. 1993;50:577–84.

    Article  PubMed  CAS  Google Scholar 

  31. Oslin DW. Evidence-based treatment of geriatric substance abuse. Psychiatr Clin North Am. 2005;28(4):897–911.

    Article  PubMed  Google Scholar 

  32. Rivers E, Shirazi E, Aurora T, et al. Cocaine use in elder patients presenting to an inner-city emergency department. Acad Emerg Med. 2004;11(8):874–7.

    Article  PubMed  Google Scholar 

  33. SAMHSA. Treatment Episode Data Set (TEDS): 1994–1999 National Admissions to Substance Abuse Treatment Services. Rockville, MD: Office of Applied Studies, Substance Abuse and Mental Health Services Administration, Department of Health and Human Services; 2000.

    Google Scholar 

  34. Weintraub E, Weintraub D, Dixon L, et al. Geriatric patients on a substance abuse consultation service. Am J Geriatr Psychiatr. 2002;10(3):337–42.

    Google Scholar 

  35. McBride DC, Inciardi JA, Chitwood DD, McCoy CB. Crack use and correlates of use in a national population of street heroin users, The National AIDS Research Consortium. J Psychoactive Drugs. 1992;24(4):411–6.

    Article  PubMed  CAS  Google Scholar 

  36. Edgell R, Kunik M, Molinari V. Nonalcohol-related use disorders in geropsychiatric patients. J Geratr Psychiatr Neurol. 2000;13(1):33–7.

    Article  CAS  Google Scholar 

  37. Schonfeld L, Dupree LW, Dickson-Euhrmann E, et al. Cognitive-behavioral treatment of older veterans with substance abuse problems. J Geriatr Psychiatr Neurol. 2000;13(3):124–9.

    CAS  Google Scholar 

  38. Cook AE. Strategies for containing drug costs: implications for a Medicare benefit. Health Care Financ Rev Spring. 1999;20(3):29–37.

    CAS  Google Scholar 

  39. Thomas CP, Ritter G, Wallack SS. Growth in prescription drug spending among insured elders. Health Aff (Millwood). 2001;20(5):265–77.

    Article  CAS  Google Scholar 

  40. Stuart B, Kamal-Bahl S, Briesacher B, et al. Trends in the prescription of inappropriate drugs for the elderly between 1995 and 1999. Am J Geriatr Pharmacother. 2003;1(2):61–74.

    Article  PubMed  Google Scholar 

  41. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. J Am Med Assoc. 1994;272(4):292–6.

    Article  CAS  Google Scholar 

  42. Zuckerman I. Inappropriate medication use and transition to nursing home among community-dwelling elders [Dissertation]. Baltimore: School of Medicine, University of Maryland Baltimore; 2005.

    Google Scholar 

  43. Zuckerman I, Byrns P, Baumgarten M, Orwig D, Langenberg P, Magaziner J. Inappropriate medication use and transition to nursing home. Paper presented at: Annual meeting of the Gerontological Society of America; 2005; Orlando, FL.

    Google Scholar 

  44. Kamal-Bahl S, Doshi J, Stuart B, Briesacher B. Propoxyphene use by community dwelling and institutionalized elderly Medicare beneficiaries. J Am Geriatr Soc. 2003;51:1099–104.

    Article  PubMed  Google Scholar 

  45. Simoni-Wastila L, Singhal PK, Hsu VD, Gardner JS, Briesacher B, Zuckerman I. Potentially problematic drug use in community-dwelling elders. Silver Spring, MD: Submitted to Johnson, Bassin, and Shaw, Inc. as part of project funded by the SAMHSA; June 24, 2003.

    Google Scholar 

  46. Simoni-Wastila L, Zuckerman I, Singhal PK, Briesacher B, Hsu VD. National estimates of exposure to prescription drugs with addiction potential in the Medicare population. Subs Abuse. 2005;26(1).

    Google Scholar 

  47. Moxey ED, O’Connor JP, Novielli KD, Teutsch S, Nash DB. Prescription drug use in the elderly: a descriptive analysis. Health Care Financ Rev. 2003;24(4):127–41.

    PubMed  Google Scholar 

  48. Gleason PP, Schulz R, Smith NL, et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med. 1998;13(4):243–50.

    Article  PubMed  CAS  Google Scholar 

  49. Blazer D, Hybels C, Simonsick E, Hanlon JT. Sedative, hypnotic, and antianxiety medication use in an aging cohort over ten years: a racial comparison. J Am Geriatr Soc. 2000;48(9):1073–9.

    PubMed  CAS  Google Scholar 

  50. Tobias D, Pulliam C. General and psychotherapeutic medication use in 878 nursing facilities. A 1997 national survey. Consultant Pharmacist. 1997;12(12):1401–1408

    Google Scholar 

  51. SAMHSA. Older adults in substance abuse treatment. The DASIS report. Drug and alcohol services information system. Rockville, MD: Office of Applied Statistics, Substance Abuse and Mental Health Service Administration, U.S. Department of Health and Human Services; 2001.

    Google Scholar 

  52. CASA. Under the rug: substance abuse and the mature woman. New York: CASA, Columbia University; 1998.

    Google Scholar 

  53. Batten H, Prottas J, Horgan C, et al. Drug services research survey. Phase II final report: NIDA; 1992.

    Google Scholar 

  54. Gfroerer J, Penne M, Pemberton M, Folsom R. Substance abuse treatment need among older adults in 2020: the impact of the aging baby-boom cohort. Drug Alcohol Depend. 2003;69(2):127–35.

    Article  PubMed  Google Scholar 

  55. Colliver J, Gfroerer J, Condon T. Projecting drug use among aging baby boomers in 2020. Ann Epidemiol. 2006;16(4):257–65.

    Article  PubMed  Google Scholar 

  56. Patterson TL, Jeste DV. The potential impact of the baby-boom generation on substance abuse among elderly persons. Psychiatr Serv. 1999;50(9):1184–8.

    PubMed  CAS  Google Scholar 

  57. Sheahan SL, Hendricks L, Coons SJ. Drug misuse among the elderly: a covert problem. Health Values. 1989;13(3):22–9.

    Google Scholar 

  58. Simoni-Wastila L, Strickler G. Risk factors for problem use of prescription drugs. Am J Public Health. 2004;94(2):266–8.

    Article  PubMed  Google Scholar 

  59. Simoni-Wastila L, Strickler G, Ritter G. Gender and other factors associated with the non-medical use of abusable prescription drugs. Substance Use Misuse. 2004;39(1):1–14.

    Article  PubMed  Google Scholar 

  60. Simoni-Wastila L. Gender and psychotropic drug use. Med Care. 1998;36(1):88–94.

    Article  PubMed  CAS  Google Scholar 

  61. Simoni-Wastila L. The use of abusable prescription drugs: the role of gender. J Womens Health Gend Based Med. 2000;9(3):289–97.

    Article  PubMed  CAS  Google Scholar 

  62. Olfson M, Pincus HA. Use of benzodiazepines in the community. Arch Intern Med. 1994;154(11):1235–40.

    Article  PubMed  CAS  Google Scholar 

  63. Hohmann AA, Larson DB, Thompson JW, Beardsley RS. Psychotropic medication prescription in U.S. ambulatory medical care. DICP. 1991;25(1):85–9.

    PubMed  CAS  Google Scholar 

  64. Takala J, Ryynanen OP, Lehtovirta E, Turakka H. The relationship between mental health and drug use. Acta Psychiatr Scand. 1993;88(4):256–8.

    Article  PubMed  CAS  Google Scholar 

  65. Swartz M, Landerman R, George LK, Melville ML, Blazer D, Smith K. Benzodiazepine anti-anxiety agents: prevalence and ­correlates of use in a southern community. Am J Public Health. 1991;81(5):592–6.

    Article  PubMed  CAS  Google Scholar 

  66. NIDA. Prescription drugs abuse and addiction: DHHS/NIH/NIDA; 2001.

    Google Scholar 

  67. SAMHSA. Summary of findings from the 1999 national household survey on drug abuse.Rockville, MD: Office of Applied Studies, Substance Abuse and Mental Health Service Administration, U.S. Department of Health and Human Services; 2000.

    Google Scholar 

  68. Johnston L, O’Malley P, Bachman J. Monitoring the future: national survey results on drug use, 1975–1999: DHHS/NIH/NIDA; 2000.

    Google Scholar 

  69. SAMHSA. Substance use among women in the United States. Rockville, MD: Office of Applied Studies, SAMHSA, U.S. Department of Health and Human Services; 1997. DHHS Publication No. SMA 97–3162.

    Google Scholar 

  70. Zickler P. NIDA scientific panel reports on prescription drug misuse and abuse. NIDA Notes. 2001:16.

    Google Scholar 

  71. Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol. 1994;2:244–68.

    Article  Google Scholar 

  72. Gomberg ESL. Older women and alcohol use and abuse. Recent developments in alcoholism. alcohol and women, vol. 12. New York: Plenum; 1995. p. 61–79.

    Google Scholar 

  73. Closser MH, Blow FC. Recent advances in addictive disorders. Special populations. Women, ethnic minorities, and the elderly. Psychiatr Clin North Am. 1993;16(1):199–209.

    PubMed  CAS  Google Scholar 

  74. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. J Am Med Assoc. 1990;264(19):2511–8.

    Article  CAS  Google Scholar 

  75. Szwabo P. Substance abuse in older women. Clin Geriatr Med. 1993;9:197–208.

    PubMed  CAS  Google Scholar 

  76. Warner LA, Kessler RC, Hughes M, Anthony JC, Nelson CB. Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatr. 1995;52(3):219–29.

    Article  PubMed  CAS  Google Scholar 

  77. Hilton ME. The demographic distribution of drinking patterns in 1984. In: Clark WB, Hilton ME, editors. Alcohol: drinking practices and problems. Albany, NY: State University of New York Press; 1991. p. 73–86.

    Google Scholar 

  78. Barnas C, Rossmann M, Roessler H, Riemer Y, Fleischhacker WW. Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: familiarity and preference. J Clin Psychopharmacol. 1992;12(6):397–402.

    Article  PubMed  CAS  Google Scholar 

  79. Golub A, Johnson BD. Variation in youthful risks of progression from alcohol and tobacco to marijuana and to hard drugs across generations. Am J Public Health. 2001;91(2):225–32.

    Article  PubMed  CAS  Google Scholar 

  80. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatr. 1997;54(4):313–21.

    Article  PubMed  CAS  Google Scholar 

  81. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatr. 1996;66(1):17–31.

    Article  CAS  Google Scholar 

  82. Dickey B, Normand SL, Weiss RD, Drake RE, Azeni H. Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv. 2002;53(7):861–7.

    Article  PubMed  Google Scholar 

  83. Iguchi MY, Handelsman L, Bickel WK, Griffiths RR. Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug Alcohol Depend. 1993;32(3):257–66.

    Article  PubMed  CAS  Google Scholar 

  84. Finlayson RE, Davis Jr LJ. Prescription drug dependence in the elderly population: demographic and clinical features of 100 patients. Mayo Clin Proc. 1994;69(12):1137–45.

    PubMed  CAS  Google Scholar 

  85. Fishbain D, Rosomoff H, Rosomoff R. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain. 1992;8:77–85.

    Article  PubMed  CAS  Google Scholar 

  86. Harstell C, Ospina M. How prevalent is chronic pain? Pain Clin Update. 2003;11(2):1–4.

    Article  Google Scholar 

  87. Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C. College on problems of drug dependence taskforce on prescription opioid non-medcial use and abuse: position statement. Drug Alcohol Depend. 2003;69:215–32.

    Article  PubMed  Google Scholar 

  88. Zacny J. Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers. Psychopharmacology (Berl). 2003;165(2):146–56.

    CAS  Google Scholar 

  89. Zacny J, Gutuerrez S. Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers. Psychopharmacol Bull. 2003;170(3):242–54.

    Article  CAS  Google Scholar 

  90. Blow F, Brower K, Schulenberg J, Demo-Dananberg L, Young J, Beresford T. The Michigan alcoholism screening test - Geriatric Version (MAST-G): a new elderly-specific screening instrument. Alcoholism: Clin Exp Res. 1992;16:372.

    Google Scholar 

  91. Kail B, DeLaRosa M. Challenges to treating the elderly Latino substance abuser: A not so hidden research agenda. J Gerontol Soc Work. 1998;30:123–41.

    Article  Google Scholar 

  92. Reid M, Anderson P. Geriatric substance use disorders. Med Clin North Am. 1997;81:999–1016.

    Article  PubMed  CAS  Google Scholar 

  93. Sarte D, Mertens J, Arean P, Weisner C. Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program. Addiction. 2004;99:1286–97.

    Article  Google Scholar 

  94. Sarte D, Mertens J, Arean P, Weisner C. Contrasting outcomes of older versus middle-aged and younger adult chemical dependency patients in a managed care program. J Studies Alcohol. 2003;64:520–30.

    Google Scholar 

  95. Kruse W. Problems and pitfalls in the use of benzodiazepines in the elderly. Drug Safety. 2000;5(5):328–44.

    Article  Google Scholar 

  96. Roy W, Griffin M. Prescribed medicines and the risk of falling. Top Geriatr Rehabil. 1990;5(20):12–20.

    Google Scholar 

  97. Fink A, Elliott M, Tsai M, Beck J. An evaluation of an intervention to assist primary care physicians in screening and educating older adults who use alcohol. J Am Med Assoc. 2005;53(11):1937–43.

    Google Scholar 

  98. Adams W, Cox N. Epidemiology of problem drinking among elderly people. Int J Addict. 1995;30:1693–716.

    PubMed  CAS  Google Scholar 

  99. Liberto J, Oslin D, Ruskin P. Alcoholism in older persons. A review of the literature. Hosp Commun Psychiatr. 1992;43:975–84.

    CAS  Google Scholar 

  100. Pringle K, Ahern F, Heller D, Gold C, Brown T. Potential for ­alcohol and prescription drug interactions in older people. J Am Geriatr Soc. 2005;53(11):1930–6.

    Article  PubMed  Google Scholar 

  101. Harwood H. Unpublished data. Falls Church, VA: The Lewin Group, Inc; 1995.

    Google Scholar 

  102. Harwood H, Fountain D, Livermore G. The economic costs of alcohol and drug abuse in the United States. Fairfax, VA: Prepared for the National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism; 1998.

    Google Scholar 

  103. SAMHSA. Year-end 1998 emergency department data from the drug abuse warning network. Rockville, MD: Office of Applied Studies, SAMHSA; 1999.

    Google Scholar 

Download references

Acknowledgments

The author would like to thank David Maccharia, PharmD and Nikki Mehdizadegan, B, both pharmacy students at the University of Maryland Baltimore School of Pharmacy, for their assistance in identifying, retrieving, and organizing relevant manuscripts.

Author information

Authors and Affiliations

  1. Peter Lamy Center on Drug Therapy and Aging, School of Pharmacy, University of Maryland Baltimore, Baltimore, MD, USA

    Linda Simoni-Wastila B.S.Pharm., Ph.D. & Hui-Wen Keri Yang Ph.D.

Authors
  1. Linda Simoni-Wastila B.S.Pharm., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hui-Wen Keri Yang Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Linda Simoni-Wastila B.S.Pharm., Ph.D. .

Editor information

Editors and Affiliations

  1. Inst. Pharmaceutical Sciences, Department of Psychopharmacology, Utrecht University, Universiteitsweg 99, Utrecht, 3584CG, Netherlands

    Joris C. Verster

  2. Dept. Psychiatry, Medical University of South Carolina, President St. 67, Charleston, 29425, South Carolina, USA

    Kathleen Brady

  3. School of Medicine, Div. Alcoholism & Drug Abuse, New York University, First Ave. 550, New York, 10016, New York, USA

    Marc Galanter

  4. Institute of Psychiatry, King's College London, National Addiction Centre, Windsor Walk 4, London, SE5 8AF, United Kingdom

    Patricia Conrod

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Simoni-Wastila, L., Yang, HW.K. (2012). Drug Abuse and Addiction in Elderly. In: Verster, J., Brady, K., Galanter, M., Conrod, P. (eds) Drug Abuse and Addiction in Medical Illness. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3375-0_37

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-3375-0_37

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-3374-3

  • Online ISBN: 978-1-4614-3375-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation